国家药监局副局长黄果在浙江调研原料药管理工作

Core Viewpoint - The National Medical Products Administration emphasizes the importance of active management and optimization of raw material drug regulation to enhance the pharmaceutical supply chain and industry innovation [1] Group 1: Regulatory Focus - The raw material drug is identified as a key component in strengthening the pharmaceutical industry supply chain [1] - Continuous optimization of raw material drug regulation is deemed essential to respond to industry development demands [1] - The administration aims to adopt an issue-oriented approach and learn from international experiences to advance regulatory reforms [1] Group 2: Industry Development - There is a strong emphasis on maintaining safety standards and enhancing quality awareness among enterprises [1] - The goal is to promote high-quality development within the raw material drug industry [1]